COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 176 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $230,697 | -0.8% | 10,322 | -4.6% | 0.00% | 0.0% |
Q2 2023 | $232,565 | -10.4% | 10,822 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $259,620 | +0.2% | 10,822 | -3.1% | 0.00% | 0.0% |
Q4 2022 | $259,005 | +44.7% | 11,164 | +0.2% | 0.00% | 0.0% |
Q3 2022 | $179,000 | -9.1% | 11,143 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $197,000 | -26.8% | 11,143 | -15.6% | 0.00% | 0.0% |
Q1 2022 | $269,000 | +6.7% | 13,203 | -2.2% | 0.00% | 0.0% |
Q4 2021 | $252,000 | -9.4% | 13,503 | -4.3% | 0.00% | 0.0% |
Q3 2021 | $278,000 | -17.3% | 14,103 | -0.7% | 0.00% | -25.0% |
Q2 2021 | $336,000 | -8.2% | 14,203 | -8.0% | 0.00% | 0.0% |
Q1 2021 | $366,000 | +1364.0% | 15,435 | +1152.8% | 0.00% | – |
Q4 2020 | $25,000 | -3.8% | 1,232 | 0.0% | 0.00% | – |
Q3 2020 | $26,000 | +18.2% | 1,232 | 0.0% | 0.00% | – |
Q2 2020 | $22,000 | -83.5% | 1,232 | -84.8% | 0.00% | -100.0% |
Q1 2020 | $133,000 | -60.3% | 8,132 | -50.0% | 0.00% | -60.0% |
Q4 2019 | $335,000 | +225.2% | 16,265 | +171.1% | 0.01% | +150.0% |
Q4 2018 | $103,000 | – | 6,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rubric Capital Management LP | 2,606,500 | $51,452,000 | 1.44% |
Camber Capital Management LP | 2,000,000 | $39,480,000 | 1.22% |
Eventide Asset Management | 2,629,593 | $51,908,000 | 0.68% |
GREAT POINT PARTNERS LLC | 121,342 | $2,395,000 | 0.56% |
RICE HALL JAMES & ASSOCIATES, LLC | 753,038 | $14,865,000 | 0.55% |
Values First Advisors, Inc. | 41,773 | $825,000 | 0.53% |
CLARK ESTATES INC/NY | 183,800 | $3,628,000 | 0.52% |
EMERALD MUTUAL FUND ADVISERS TRUST | 710,398 | $14,023,000 | 0.48% |
EMERALD ADVISERS, LLC | 590,256 | $11,652,000 | 0.42% |
ACORN FINANCIAL ADVISORY SERVICES INC /ADV | 68,812 | $1,358,000 | 0.42% |